Journal
JOURNAL OF ORGANIC CHEMISTRY
Volume 86, Issue 7, Pages 5091-5101Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.joc.0c03019
Keywords
-
Categories
Funding
- KAKENHI [20H03362, 19K16312]
- Japan Agency for Medical Research and Development (AMED) (Platform Project for Supporting Drug Discovery and Life Science Research, BINDS) [JP20am0101098]
- Cooperative Research Project of Research Center for Biomedical Engineering
- Uehara Memorial Foundation
- Grants-in-Aid for Scientific Research [20H03362, 19K16312] Funding Source: KAKEN
Ask authors/readers for more resources
This study reports improved methods for convergent synthesis using a chloroalkene dipeptide isostere (CADI), demonstrating the direct application of Fmoc-protected CADI in solid-phase peptide synthesis and the discovery of a CADI-containing peptidomimetic with superior inhibitory effects on amyloid-beta aggregation compared to the parent peptide.
Improved methods of convergent synthesis for peptidomimetic utilizing a chloroalkene dipeptide isostere (CADI) are reported. In this synthesis, Fmoc- or Boc-protected carboxylic acids can be produced from N- and C-terminal analogues corresponding to each amino acid starting material via an Evans syn aldol reaction, followed by a [3.3] sigmatropic rearrangement utilizing the Ichikawa allylcyanate rearrangement reaction. With this strategy, an Fmoc-protected CADI can be directly applied for solid-phase peptide synthesis. Using this approach, we have also identified the CADI-containing cyclo[-Lys-Leu-Val-Phe-Phe-] peptidomimetic, which is a superior inhibitor of amyloid-beta aggregation than the parent peptide.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available